DERMATA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.78
-6.65%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-30.2%
3 months
-27.9%
6 months
-41.7%
1 year
-77.4%
Year to date
-66.6%
52-week range
$0.66 – $3.43
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.1M
P/E
-0.4
P/B
0.9
P/S
—
Revenue
$0
Net income
-$8.37M
Diluted EPS
-4.39
Gross margin
—
Net margin
—
Return on equity
-166.70%
Total debt
$0
Cash
$4.41M
Free cash flow
-$8.03M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$2.97M | — | — | -$2.42M |
| Mar 31, 2026 | $0 | -$1.85M | — | — | -$2.48M |
| Dec 31, 2025 | $0 | -$1.86M | — | — | -$1.33M |
| Sep 30, 2025 | $0 | -$1.69M | — | — | -$1.8M |
| Jun 30, 2025 | $0 | -$1.7M | — | — | -$2.69M |
| Mar 31, 2025 | $0 | -$2.3M | — | — | -$1.93M |
| Dec 31, 2024 | $0 | -$3.15M | — | — | -$2.91M |
| Sep 30, 2024 | $0 | -$3.17M | — | — | -$3.42M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent DRMA news
All market newsNo ticker-linked stories are in the current archive.